GMAB vs. VRTX
Compare and contrast key facts about Genmab A/S (GMAB) and Vertex Pharmaceuticals Incorporated (VRTX).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: GMAB or VRTX.
Key characteristics
| GMAB | VRTX | |
|---|---|---|
| YTD Return | -15.52% | 19.29% |
| 1Y Return | -30.18% | 38.91% |
| 3Y Return (Ann) | -15.04% | 37.20% |
| 5Y Return (Ann) | 6.05% | 22.68% |
| 10Y Return (Ann) | 20.92% | 17.90% |
| Sharpe Ratio | -0.78 | 1.69 |
| Daily Std Dev | 33.16% | 23.68% |
| Max Drawdown | -84.20% | -91.77% |
| Current Drawdown | -44.79% | -4.04% |
Fundamentals
| GMAB | VRTX | |
|---|---|---|
| Market Cap | $17.08B | $125.27B |
| EPS | $1.25 | -$1.99 |
| PEG Ratio | 0.94 | 0.59 |
| Total Revenue (TTM) | $20.23B | $10.32B |
| Gross Profit (TTM) | $19.62B | $8.92B |
| EBITDA (TTM) | $6.03B | -$20.80M |
Correlation
The correlation between GMAB and VRTX is 0.21, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
GMAB vs. VRTX - Performance Comparison
In the year-to-date period, GMAB achieves a -15.52% return, which is significantly lower than VRTX's 19.29% return. Over the past 10 years, GMAB has outperformed VRTX with an annualized return of 20.92%, while VRTX has yielded a comparatively lower 17.90% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
GMAB vs. VRTX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Genmab A/S (GMAB) and Vertex Pharmaceuticals Incorporated (VRTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
GMAB vs. VRTX - Dividend Comparison
Neither GMAB nor VRTX has paid dividends to shareholders.
Drawdowns
GMAB vs. VRTX - Drawdown Comparison
The maximum GMAB drawdown since its inception was -84.20%, smaller than the maximum VRTX drawdown of -91.77%. Use the drawdown chart below to compare losses from any high point for GMAB and VRTX. For additional features, visit the drawdowns tool.
Volatility
GMAB vs. VRTX - Volatility Comparison
Genmab A/S (GMAB) and Vertex Pharmaceuticals Incorporated (VRTX) have volatilities of 6.34% and 6.35%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Financials
GMAB vs. VRTX - Financials Comparison
This section allows you to compare key financial metrics between Genmab A/S and Vertex Pharmaceuticals Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities